Itriage_logo_homepage
 

Pulmonary Fibrosis (Lung Scarring)

Description

Description

Scarring in the lungs. The disorder can be caused by many conditions including: chronic inflammatory processes (sarcoidosis, Wegener's granulomatosis, lupus, rheumatoid arthritis), infections, environmental agents (asbestos, silica, exposure to certain gases), exposure to ionizing radiation (such as radiation therapy to treat cancer), and certain medications (nitrofurantoin, methotrexate).

Symptoms

Symptoms

Chest pain (occasionally), cough (usually dry), exercise intolerance, shortness of breath, fatigue.

Tests

Tests

A history and physical exam will be performed. The following test may be performed to help establish the diagnosis: bronchoscopy with transbronchial lung biopsy, pulmonary function tests, surgical lung biopsy. Blood tests to diagnose the following autoimmune diseases may be done: rheumatoid arthritis, lupus, and/or scleroderma.

Standard Workup
  • CBC
  • Chem 12
  • X-Ray
  • CT Scan
  • MRI
Treatment

Treatment

There is no cure for pulmonary fibrosis. Treatment is aimed at slowing down the scarring process and preventing hypoxia (low oxygen levels). Medications such as corticosteroids and immunosuppressive medications (cyclophosphamide, azathioprine, methotrexate, penicillamine, cyclosporine) may be given to reduce the inflammation and scarring, but these treatments are not very effective. Oxygen is administered for low blood oxygen levels. For additional information contact the National Heart, Lung and Blood Institute Health Information Center at: http://www.nhlbi.nih.gov or call (301)592-8573. American Lung Association: (800)586-4872 National Jewish Medical and Research Center: (800)222-5864




News

News

A new scan for lung diseases

( University of Nottingham ) People with chronic lu...

From: EurekAlert!
For Creating A Molecular Roadmap For Chronic Lung Diseases NHLBI Awards $11 Million

National Jewish Health and four other research cent...

From: Medical News Today
Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results

Pharmaceutical company Pharmaxis (ASX: PXS) announc...

From: Medical News Today
Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results

BALTIMORE, Oct. 22 /PRNewswire/ -- Pharmaceutical c...

From: redOrbit
Critically ill patients appeal for organ donors

KUALA LUMPUR: Azaryna Noh was looking forward to a ...

From: New Straits Times

Find Medical Help & Treament Near You
Acute Care Facilities
Other Providers Treating this Disease
Medications Treating This Disease

Emergency Room
Sort by: Distance | Featured
Comments-icon

Share Your Experience

Do you have experience with this disease? Do you or someone
you know suffer from Pulmonary fibrosis (Lung scarring)?

Please share you experience with other members of the iTriage community.

There are no comments

This page is:

  Useful      Confusing      Broken